Skip to main content

Ana Barreira Diaz

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Ana Barreira Diaz

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Projects

Impact of HLA haplotypes and HDV viremia in developing of clinical events and quality of life of patients with chronic hepatitis delta.

IP: Maria Buti Ferret
Collaborators: Maria Jose Herrero Mata, Ana Barreira Diaz, Maria del Mar Riveiro Barciela, Jordi Llaneras Artigues, Adriana Palom Agusti
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI20/01692
Duration: 01/01/2021 - 30/06/2025

Related news

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Urcelay Ganzabal, Amaia

Urcelay Ganzabal, Amaia

Multidisciplinary Nursing Research Group
Read more
Ángela Sánchez Osuna

Ángela Sánchez Osuna

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Moreno Perez, Elena

Moreno Perez, Elena

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Ángeles Mesas Idáñez

Ángeles Mesas Idáñez

Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.